Johnson M, Garassino MC, Mok T, Mitsudomi T, et al. Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies. Lung Cancer 2022;170:41-51.
PMID: 35714425